Management of a primary malignant melanoma of uterine cervix stage IVA patient with radical surgery and adjuvant oncolytic virus Rigvir® therapy: A case report

Management of a primary malignant melanoma of uterine cervix stage IVA patient with radical surgery and adjuvant oncolytic virus Rigvir® therapy: A case report

Abstract Primary malignant melanoma of the uterine cervix is a rare disease with poor prognosis and high recurrence rate. We used Rigvir® as adjuvant therapy for a stage IVA patient. Tolerability, overall and progression‐free survival are good.

Bibliographic Details
Main Authors: Elizabete Pumpure, Eva Dručka, Dana Kigitoviča, Raimundas Meškauskas, Sergejs Isajevs, Ineta Nemiro, Agnija Rasa, Evija Olmane, Tatjana Zablocka, Pēteris Alberts, Simona Doniņa
Format: Article
Language:English
Published: Wiley 2020-08-01
Series:Clinical Case Reports
Subjects:
ECHO‐7 virus
melanoma
oncology
oncolytic virus
Rigvir
uterine cervix
Online Access:https://doi.org/10.1002/ccr3.2928
id doaj-b5343f8dc6e245e9b9688295ac08bda0
record_format Article
spelling doaj-b5343f8dc6e245e9b9688295ac08bda02020-11-25T03:40:16ZengWileyClinical Case Reports2050-09042020-08-01881538154310.1002/ccr3.2928Management of a primary malignant melanoma of uterine cervix stage IVA patient with radical surgery and adjuvant oncolytic virus Rigvir® therapy: A case reportElizabete Pumpure0Eva Dručka1Dana Kigitoviča2Raimundas Meškauskas3Sergejs Isajevs4Ineta Nemiro5Agnija Rasa6Evija Olmane7Tatjana Zablocka8Pēteris Alberts9Simona Doniņa10Department of Obstetrics and Gynaecology Riga Stradiņš University Riga LatviaDepartment of Internal Diseases Riga Stradiņš University Riga LatviaDepartment of Internal Diseases Riga Stradiņš University Riga LatviaNational Center of Pathology Affiliate of Vilnius University Hospital Santaros Klinikos Vilnius LithuaniaCentre of Pathology Riga Eastern Clinical University Hospital Riga LatviaDepartment of Diagnostic Radiology Oncology Centre of Latvia Riga LatviaR&D, Rigvir Riga LatviaDepartment of Radiology Pauls Stradiņš Clinical University Hospital Riga LatviaCentre of Pathology Riga Eastern Clinical University Hospital Riga LatviaR&D, Rigvir Riga LatviaOncology Centre of Latvia Riga East University Hospital Riga LatviaAbstract Primary malignant melanoma of the uterine cervix is a rare disease with poor prognosis and high recurrence rate. We used Rigvir® as adjuvant therapy for a stage IVA patient. Tolerability, overall and progression‐free survival are good.https://doi.org/10.1002/ccr3.2928ECHO‐7 virusmelanomaoncologyoncolytic virusRigviruterine cervix
collection DOAJ
language English
format Article
sources DOAJ
author Elizabete Pumpure
Eva Dručka
Dana Kigitoviča
Raimundas Meškauskas
Sergejs Isajevs
Ineta Nemiro
Agnija Rasa
Evija Olmane
Tatjana Zablocka
Pēteris Alberts
Simona Doniņa
spellingShingle Elizabete Pumpure
Eva Dručka
Dana Kigitoviča
Raimundas Meškauskas
Sergejs Isajevs
Ineta Nemiro
Agnija Rasa
Evija Olmane
Tatjana Zablocka
Pēteris Alberts
Simona Doniņa
Management of a primary malignant melanoma of uterine cervix stage IVA patient with radical surgery and adjuvant oncolytic virus Rigvir® therapy: A case report
Clinical Case Reports
ECHO‐7 virus
melanoma
oncology
oncolytic virus
Rigvir
uterine cervix
author_facet Elizabete Pumpure
Eva Dručka
Dana Kigitoviča
Raimundas Meškauskas
Sergejs Isajevs
Ineta Nemiro
Agnija Rasa
Evija Olmane
Tatjana Zablocka
Pēteris Alberts
Simona Doniņa
author_sort Elizabete Pumpure
title Management of a primary malignant melanoma of uterine cervix stage IVA patient with radical surgery and adjuvant oncolytic virus Rigvir® therapy: A case report
title_short Management of a primary malignant melanoma of uterine cervix stage IVA patient with radical surgery and adjuvant oncolytic virus Rigvir® therapy: A case report
title_full Management of a primary malignant melanoma of uterine cervix stage IVA patient with radical surgery and adjuvant oncolytic virus Rigvir® therapy: A case report
title_fullStr Management of a primary malignant melanoma of uterine cervix stage IVA patient with radical surgery and adjuvant oncolytic virus Rigvir® therapy: A case report
title_full_unstemmed Management of a primary malignant melanoma of uterine cervix stage IVA patient with radical surgery and adjuvant oncolytic virus Rigvir® therapy: A case report
title_sort management of a primary malignant melanoma of uterine cervix stage iva patient with radical surgery and adjuvant oncolytic virus rigvir® therapy: a case report
publisher Wiley
series Clinical Case Reports
issn 2050-0904
publishDate 2020-08-01
description Abstract Primary malignant melanoma of the uterine cervix is a rare disease with poor prognosis and high recurrence rate. We used Rigvir® as adjuvant therapy for a stage IVA patient. Tolerability, overall and progression‐free survival are good.
topic ECHO‐7 virus
melanoma
oncology
oncolytic virus
Rigvir
uterine cervix
url https://doi.org/10.1002/ccr3.2928
work_keys_str_mv AT elizabetepumpure managementofaprimarymalignantmelanomaofuterinecervixstageivapatientwithradicalsurgeryandadjuvantoncolyticvirusrigvirtherapyacasereport
AT evadrucka managementofaprimarymalignantmelanomaofuterinecervixstageivapatientwithradicalsurgeryandadjuvantoncolyticvirusrigvirtherapyacasereport
AT danakigitovica managementofaprimarymalignantmelanomaofuterinecervixstageivapatientwithradicalsurgeryandadjuvantoncolyticvirusrigvirtherapyacasereport
AT raimundasmeskauskas managementofaprimarymalignantmelanomaofuterinecervixstageivapatientwithradicalsurgeryandadjuvantoncolyticvirusrigvirtherapyacasereport
AT sergejsisajevs managementofaprimarymalignantmelanomaofuterinecervixstageivapatientwithradicalsurgeryandadjuvantoncolyticvirusrigvirtherapyacasereport
AT inetanemiro managementofaprimarymalignantmelanomaofuterinecervixstageivapatientwithradicalsurgeryandadjuvantoncolyticvirusrigvirtherapyacasereport
AT agnijarasa managementofaprimarymalignantmelanomaofuterinecervixstageivapatientwithradicalsurgeryandadjuvantoncolyticvirusrigvirtherapyacasereport
AT evijaolmane managementofaprimarymalignantmelanomaofuterinecervixstageivapatientwithradicalsurgeryandadjuvantoncolyticvirusrigvirtherapyacasereport
AT tatjanazablocka managementofaprimarymalignantmelanomaofuterinecervixstageivapatientwithradicalsurgeryandadjuvantoncolyticvirusrigvirtherapyacasereport
AT peterisalberts managementofaprimarymalignantmelanomaofuterinecervixstageivapatientwithradicalsurgeryandadjuvantoncolyticvirusrigvirtherapyacasereport
AT simonadonina managementofaprimarymalignantmelanomaofuterinecervixstageivapatientwithradicalsurgeryandadjuvantoncolyticvirusrigvirtherapyacasereport
_version_ 1724535173587927040

Similar Items